---
schema_version: "secwatch.filing_event.v1"
accession: "0001789769-24-000075"
form_type: "8-K"
ticker: "TIL"
cik: "0001789769"
company_name: "Instil Bio, Inc."
filed_at: "2024-07-11T23:59:59+00:00"
generated_at: "2026-05-31T21:48:43.133918+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Instil Bio leases Tarzana facility to AstraZeneca for ~15 years at $7.5M/yr initial rent

## Summary
- Initial term ~15 years from July 10, 2024 to July 31, 2039; two 5-year extension options.
- Initial base rent $627,276/month ($7,527,312 annually) escalating 3% per annum.
- Tenant has one-time option to terminate at 10th anniversary with termination fee.
- Rent abatement during first year; Tenant also pays certain operating and tax expenses.
- Tenant granted a right of first offer to purchase the leased premises.

## SEC filing metadata
- accession: 0001789769-24-000075
- form_type: 8-K
- ticker: TIL
- cik: 0001789769
- company_name: Instil Bio, Inc.
- filed_at: 2024-07-11T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1789769/000178976924000075/0001789769-24-000075-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1789769/000178976924000075/til-20240710.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001789769-24-000075
- JSON: https://secwatch.observer/filing/0001789769-24-000075.json
- Plain text: https://secwatch.observer/filing/0001789769-24-000075.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.